Helda Bacall
Family · Detroit, MINPI 1134731466
Payments from drug & device makers
Across 63 payments — averaging $143.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- Janssen Scientific Affairs, LLC$579
- Astellas Pharma US Inc$375
- AstraZeneca$341
- Seagen Inc.$308
- Exelixis Inc.$290
- plus $969 from 11 others
What the payments were for
- Consulting fees$5636%
- Speaking & faculty fees$4,85054%
- Travel & lodging$6227%
- Food & beverage$2,20124%
- Education$8089%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 21 | $6,181 |
| Janssen Scientific Affairs, LLC | 2 | $579 |
| Astellas Pharma US Inc | 4 | $375 |
| AstraZeneca | 5 | $341 |
| Seagen Inc. | 4 | $308 |
| Exelixis Inc. | 4 | $290 |
| AVEO Pharmaceuticals, Inc. | 2 | $191 |
| Daiichi Sankyo Inc. | 4 | $155 |
| Bayer | 2 | $152 |
| Gilead | 1 | $120 |
| Johnson & Johnson | 2 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| Astellas Pharma Global Development | 3 | $70 |
| Eisai Inc. | 2 | $49 |
| EMD Serono, Inc. | 1 | $24 |
| Novartis | 1 | $24 |
| Myovant Sciences Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,043 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 144 | $1,199,628 |
| CabometyxCabozantinib S-Malate | 43 | $1,046,807 |
| OrgovyxRelugolix | 164 | $418,578 |
| NubeqaDarolutamide | 28 | $251,172 |
| Pazopanib Hcl | 26 | $173,266 |
| Abiraterone Acetate | 114 | $62,656 |
| Prednisone | 126 | $558 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $260 |
| Megestrol Acetate | 13 | $172 |
| Ondansetron Hcl | 16 | $160 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $155 |
| Tamsulosin Hcl | 13 | $52 |
| Famotidine | 17 | $47 |
| Amlodipine Besylate | 15 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi | $375 | $1,199,628144 claims |
| Exelixis Inc.Cabometyx | $290 | $1,046,80743 claims |
| Sumitomo Pharma America, Inc.Orgovyx | $73 | $418,578164 claims |
| BayerNubeqa | $152 | $251,17228 claims |
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $579 | $62,656114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Detroit
- Elisheva EllenbergDetroit$150K
- Michelle ThomasDetroit$36K
- Danielle BlakeDetroit$34K
- Lauren JuddDetroit$15K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.